Patient #11, a 23-year-old male with cystic fibrosis who developed a multidrug resistant Burkholderia gladioli infection in his chest cavity prior to a lung transplant in 2017. Since the transplant, the patient suffered from a sternal wound infection and recurrent bacteremia caused by the same bacterial pathogen. Phage therapy was initiated in early November 2018. The doctor reported marked clinical improvement after 11 days of treatment. After 35 doses of phage therapy, the patient had significant radiological improvement and was culture negative.  Patient is stable with significant clinical improvement of his sternal wound and has remained culture